LPH-5 (drug)

LPH-5
Clinical data
Other names	(S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine; (S)-2C-TFM-3PIP; (S)-β,N-Trimethylene-2C-TFM
Drug class	Selective serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen; Antidepressant
ATC code	None;
Legal status
Legal status	In general unscheduled;
Identifiers
	IUPAC name (S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine;
CAS Number	2641630-97-7 ;
PubChem CID	156337168;
ChemSpider	129385919;
ChEMBL	ChEMBL5531940;
Chemical and physical data
Formula	C14H18F3NO2
Molar mass	289.298 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=CC([C@@]2([H])CNCCC2)=C(OC)C=C1C(F)(F)F;
	InChI InChI=1S/C14H18F3NO2/c1-19-12-7-11(14(15,16)17)13(20-2)6-10(12)9-4-3-5-18-8-9/h6-7,9,18H,3-5,8H2,1-2H3/t9-/m1/s1; Key:NZKYTYHIERLZBG-SECBINFHSA-N;

LPH-5, also known as (S)-3-(2,5-dimethoxy-4-(trifluoromethyl)phenyl)piperidine or as (S)-2C-TFM-3PIP, is a psychedelic drug of the phenethylamine, 2C, and 3-phenylpiperidine families which is under development for potential medical use. It is a cyclized phenethylamine and is the derivative of 2C-TFM in which the β position has been connected to the amine to form a piperidine ring.